Daily Newsletter

11 August 2023

Daily Newsletter

11 August 2023

Motus GI secures approval in Israel for Pure-VuEVS System

The system helps physicians manage urgent or complex colonoscopies.

RanjithKumar Dharma August 11 2023

Motus GI Holdings has secured approval from the Israeli Ministry of Health, Medical Device Division (AMAR) for initiating commercial sales of its Pure-Vu EVS System in the country.

To enhance visualisation during colonoscopy without disrupting the established procedural workflow and techniques, the Pure-Vu EVS System can be integrated with both standard and slim colonoscopes.

It is a single-use oversleeve intended to deliver better-quality exams by irrigating and evacuating debris.

The system assists physicians in managing urgent or complex colonoscopies by quickly and safely offering a clear view of the colon wall.

It is powered by three proprietary technologies for safe intraprocedural cleansing of the colon walls.

The technologies include Pulsed Vortex for irrigation, Smart Sense for suction and Smooth Glide for navigation.

The US Food and Drug Administration has already approved the Pure-Vu EVS for aiding in the cleansing of a poorly prepared gastrointestinal tract during colonoscopy.

Motus GI CEO Mark Pomeranz said: “We are pleased to secure regulatory clearance for the Pure-Vu EVS System in Israel, which is considered an advanced medical system globally and one of the largest markets in this region.

“Leading healthcare systems in a number of regions in the US and the Veterans Health Administration are currently utilising the Pure-Vu EVS System.

“Gaining regulatory approval in various regions of the world supports our strategy to enable strategic partnerships with medical device companies on a global basis.”

With subsidiaries in Israel and the US, Motus GI offers endoscopy solutions for the diagnosis and management of gastrointestinal conditions.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.